Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
Robbins Geller Rudman & Dowd LLP announces a lead plaintiff deadline of April 6, 2026, for investors with substantial losses in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE). The class action lawsuit alleges that Ultragenyx made misleading statements regarding its Phase III Orbit and Cosmic studies for Osteogenesis Imperfecta, failing to disclose risks and later announcing the studies did not achieve statistical significance. The firm encourages affected investors to seek appointment as lead plaintiff.